drugset / Trial / NCT06448026
Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
To learn if giving cemiplimab and cetuximab before salvage surgery can help to control recurrent oral cavity squamous cell carcinoma.
Timeline
- Start
- 2024-11-21
- Primary completion
- 2027-05-15
- Completion
- 2027-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cemiplimab | Monoclonal antibody | — | Intravenous |
| Subject | Cetuximab | Monoclonal antibody | — | Intravenous |